Alnylam Pharmaceuticals | Despesas Operacionais



Operating Expenses Alterar Data
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Moderna USD 1.16B 1.06B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 10.15B 579M 2024-12
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sanofi EUR 6.77B 3.75B 2024-12
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Takeda JPY 1.13T 51.15B 2025-03
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Xencor USD 75.91M 9.94M 2025-03



Alnylam Pharmaceuticals Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.